SnowPJD. Effect of propranolol in myocardial infarction. Lancet1965; 2: 551–3.
2.
PrattCMRobertsR. Chronic beta-blockade therapy in patients after myocardial infarction. Am J Cardiol1983; 52: 661–4.
3.
TaylorSH. Secondary prevention after myocardial infarction: Facts or fallacies. J Cardiovasc Pharmacol1984; 6: S914–21.
4.
RotmenschHHVlassesPHFergusonRK. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction. Heart Lung1984: 13: 366–71.
5.
Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med1981; 304: 801–7.
6.
Beta-Blocker Heart Attack Trial Research Group.A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA1982; 247: 1707–14.
7.
HjalmarsonÅElmfeldtDHerlitzJ. Effect on mortality of metoprolol in acute myocardial infarction: A double-blind randomized trial. Lancet1981; 2: 823–7.
8.
DavisHTDecamillaJBayerLWMossAJ. Survivorship patterns in the post-hospital phase of myocardial infarction. Circulation1979; 60: 1252–8.
9.
TherouxPWatersDDHalphenCDebuisieuxJ-CMizgalaHF. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med1979; 301: 341–5.
10.
Multicenter Postinfarction Research Group.Risk stratification and survival after myocardial infarction. N Engl J Med1983; 309: 331–6.
11.
HjalmarsonÅ. Early intervention with a beta-blocking drug after acute myocardial infarction. Am J Cardiol1984; 54: 11–13-E.
12.
DalenJEGoldbergRJGoreJMStruckusJ. Therapeutic interventions in acute myocardial infarction. Survey of the ACCP section of clinical cardiology. Chest1984; 86: 257–62.
13.
BakerNSJulianDGLewisJARoseG. Beta-blockers after myocardial infarction: Have trials changed practice?Br Med J1984; 289: 1431–2.
